The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rates of germline genetic testing and DNA damage response mutations found through population-based recruitment of men with incident metastatic prostate cancer.
 
Hiba Khan
No Relationships to Disclose
 
Risa Liang Wong
No Relationships to Disclose
 
Burcu Darst
No Relationships to Disclose
 
Colin C. Pritchard
Consulting or Advisory Role - AstraZeneca; Sana Biotechnology
Research Funding - Color Genomics (I)
 
Peter Nelson
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen Oncology; Roche/Genentech
Research Funding - Genomic Health (Inst)
Expert Testimony - Venable
Travel, Accommodations, Expenses - Janssen Oncology
 
Janet L. Stanford
No Relationships to Disclose
 
Daniel W. Lin
Consulting or Advisory Role - Astellas Pharma; Clovis Oncology; Dendreon
Research Funding - GenomeDx (Inst); Genomic Health (Inst); Magforce (Inst); MDxHealth (Inst)
 
Heather H. Cheng
Consulting or Advisory Role - AstraZeneca; AstraZeneca (I)
Research Funding - Clovis Oncology (Inst); Color Genomics Foundation (Inst); Fred Hutchinson Cancer Research Center (Inst); Janssen (Inst); Medivation/Astellas (Inst); Phosplatin Therapeutics (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate